MICAFUNGIN SODIUM

MICAFUNGIN SODIUM was reported 6576 times

MICAFUNGIN SODIUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BENIGN RECURRENT INTRAHEPATIC CHOLESTASIS 11 0.8462
1 ANTI FACTOR V ANTIBODY 19 0.6786
2 WEISSELLA INFECTION 7 0.6364
3 PRE-ENGRAFTMENT IMMUNE REACTION 44 0.5500
4 PULMONARY TRICHOSPORONOSIS 8 0.3478
5 MENINGITIS ASPERGILLUS 4 0.2857
6 ENCEPHALITIS JAPANESE B 4 0.2222
7 CORYNEBACTERIUM BACTERAEMIA 17 0.2000
8 MINIMUM INHIBITORY CONCENTRATION INCREASED 4 0.2000
9 PARANASAL SINUS MASS 4 0.1818
10 GEOTRICHUM INFECTION 30 0.1422
11 GASTROINTESTINAL MUCORMYCOSIS 23 0.1377
12 CEREBRAL VENTRICLE COLLAPSE 10 0.1333
13 MYCOTIC ENDOPHTHALMITIS 21 0.1111
14 PULMONARY MUCORMYCOSIS 48 0.0909
15 MENINGITIS ENTEROCOCCAL 7 0.0886
16 HEPATIC CANDIDIASIS 6 0.0882
17 TRICHOSPORON INFECTION 35 0.0864
18 DISSEMINATED MUCORMYCOSIS 34 0.0863
19 FLUOROSIS 7 0.0814
20 ENGRAFT FAILURE 20 0.0697
21 GRAFT VERSUS HOST DISEASE IN INTESTINE 9 0.0692
22 HAEMORRHAGIC NECROTIC PANCREATITIS 5 0.0667
23 CEREBRAL ASPERGILLOSIS 40 0.0650
24 FUSARIUM INFECTION 44 0.0629
25 BLOOD BETA-D-GLUCAN INCREASED 19 0.0619
26 RHINOCEREBRAL MUCORMYCOSIS 21 0.0605
27 PERIHEPATIC ABSCESS 5 0.0602
28 NASAL FLARING 8 0.0593
29 FUNGAL ENDOCARDITIS 17 0.0565
30 ENCEPHALITIS FUNGAL 5 0.0556
31 CYSTITIS VIRAL 21 0.0548
32 CRYPTOCOCCAL MENINGOENCEPHALITIS 7 0.0534
33 MYELOBLAST COUNT INCREASED 4 0.0519
34 DISSEMINATED ASPERGILLOSIS 24 0.0508
35 IDIOPATHIC PNEUMONIA SYNDROME 15 0.0503
36 BILOMA 7 0.0496
37 FUNGAL DISEASE CARRIER 5 0.0495
38 BONE MARROW LEUKAEMIC CELL INFILTRATION 4 0.0488
39 FUNGAEMIA 76 0.0483
40 SCEDOSPORIUM INFECTION 34 0.0482
41 NASAL ABSCESS 11 0.0476
42 HYPEROXALURIA 8 0.0465
43 LYMPHOID TISSUE HYPOPLASIA 7 0.0458
44 ASPERGILLUS TEST POSITIVE 14 0.0455
45 ENCEPHALITIS VIRAL 55 0.0452
46 STENOTROPHOMONAS TEST POSITIVE 6 0.0448
47 PHAEHYPHOMYCOSIS 6 0.0448
48 SYSTEMIC MYCOSIS 52 0.0445
49 BORDETELLA INFECTION 4 0.0444
50 PERIOSTITIS 19 0.0440
51 ADENOVIRAL HEPATITIS 10 0.0426
52 CAPNOCYTOPHAGA INFECTION 4 0.0426
53 HUMAN HERPESVIRUS 6 ENCEPHALITIS 12 0.0423
54 INTRAOCULAR PRESSURE TEST 10 0.0417
55 MUCORMYCOSIS 107 0.0411
56 GASTROINTESTINAL FUNGAL INFECTION 21 0.0408
57 PHOSPHOLIPIDOSIS 4 0.0404
58 STOMATOCOCCAL INFECTION 5 0.0403
59 BURKHOLDERIA TEST POSITIVE 5 0.0403
60 THYMUS HYPOPLASIA 7 0.0402
61 ENTEROCOCCAL SEPSIS 32 0.0395
62 BACTERIAL TOXAEMIA 5 0.0388
63 ADENOVIRAL HAEMORRHAGIC CYSTITIS 8 0.0385
64 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 54 0.0382
65 LACTOBACILLUS INFECTION 6 0.0366
66 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 26 0.0362
67 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 98 0.0354
68 CENTRAL NERVOUS SYSTEM FUNGAL INFECTION 8 0.0345
69 HUMAN HERPESVIRUS 6 INFECTION 65 0.0344
70 EYE INFECTION FUNGAL 13 0.0336
71 ALLERGIC TRANSFUSION REACTION 5 0.0331
72 SYSTEMIC CANDIDA 83 0.0330
73 CANDIDA ENDOPHTHALMITIS 4 0.0328
74 CYTOMEGALOVIRUS TEST POSITIVE 57 0.0320
75 HEPATIC VEIN OCCLUSION 5 0.0316
76 BACTERIAL TRANSLOCATION 10 0.0315
77 SINUSITIS FUNGAL 25 0.0312
78 CANDIDA TEST POSITIVE 13 0.0311
79 OSTEOMYELITIS FUNGAL 5 0.0299
80 ANTITHROMBIN III DECREASED 8 0.0293
81 CHRONIC GRAFT VERSUS HOST DISEASE IN LUNG 5 0.0289
82 ABSCESS FUNGAL 5 0.0286
83 PANOPHTHALMITIS 5 0.0273
84 HEPATOSPLENIC CANDIDIASIS 4 0.0272
85 ENGRAFTMENT SYNDROME 16 0.0271
86 MENINGOENCEPHALITIS HERPETIC 12 0.0268
87 PLASMA CELL LEUKAEMIA 16 0.0267
88 GRAFT VERSUS HOST DISEASE IN LIVER 19 0.0265
89 ASPERGILLUS INFECTION 174 0.0265
90 NECROTISING OESOPHAGITIS 13 0.0261
91 SINUS POLYP 15 0.0260
92 PARENTERAL NUTRITION 6 0.0260
93 FACTOR V INHIBITION 5 0.0258
94 ALLOGENIC STEM CELL TRANSPLANTATION 4 0.0253
95 PYROGLUTAMIC ACIDOSIS 10 0.0252
96 ACUTE MYELOID LEUKAEMIA RECURRENT 54 0.0251
97 DISSEMINATED CRYPTOCOCCOSIS 19 0.0251
98 CEREBRAL FUNGAL INFECTION 7 0.0247
99 ENCEPHALITIS HERPES 12 0.0243
100 ALTERNARIA INFECTION 9 0.0242
101 ACUTE PROMYELOCYTIC LEUKAEMIA DIFFERENTIATION SYNDROME 5 0.0240
102 GLOMERULOSCLEROSIS 15 0.0237
103 ZYGOMYCOSIS 11 0.0235
104 BRONCHOPULMONARY ASPERGILLOSIS 182 0.0235
105 CITROBACTER INFECTION 10 0.0233
106 BRONCHIOLITIS OBLITERANS SYNDROME 4 0.0229
107 ENTEROCOCCAL BACTERAEMIA 24 0.0226
108 PNEUMONIA FUNGAL 89 0.0225
109 DELAYED GRAFT FUNCTION 16 0.0225
110 INFECTIVE ANEURYSM 11 0.0222
111 CYTOMEGALOVIRUS ENTEROCOLITIS 17 0.0221
112 OPHTHALMIC VEIN THROMBOSIS 5 0.0207
113 PULMONARY MYCOSIS 16 0.0205
114 STENOTROPHOMONAS INFECTION 27 0.0199
115 GASTROINTESTINAL MUCOSAL DISORDER 13 0.0198
116 MUCOSAL EROSION 18 0.0198
117 ACUTE GRAFT VERSUS HOST DISEASE 90 0.0196
118 BRONCHIAL HAEMORRHAGE 6 0.0192
119 CRYPTOSPORIDIOSIS INFECTION 10 0.0190
120 CANDIDA SEPSIS 17 0.0190
121 HUMAN POLYOMAVIRUS INFECTION 10 0.0188
122 ENTEROCOCCUS TEST POSITIVE 12 0.0185
123 REACTIVE GASTROPATHY 7 0.0183
124 VIRAL HAEMORRHAGIC CYSTITIS 13 0.0183
125 MYCOPLASMA INFECTION 14 0.0179
126 DYSBIOSIS 14 0.0171
127 FUNGAL OESOPHAGITIS 12 0.0170
128 CORYNEBACTERIUM INFECTION 9 0.0168
129 GRAFT VERSUS HOST DISEASE IN SKIN 37 0.0168
130 GRAFT VERSUS HOST DISEASE IN LUNG 8 0.0167
131 DIFFERENTIATION SYNDROME 12 0.0163
132 BACTERIAL SEPSIS 52 0.0160
133 BACTERIURIA 9 0.0159
134 KLEBSIELLA BACTERAEMIA 15 0.0158
135 CAVERNOUS SINUS THROMBOSIS 4 0.0157
136 FUNGAL SEPSIS 13 0.0156
137 TRACHEOBRONCHITIS 12 0.0156
138 MEDIASTINITIS 9 0.0155
139 PSEUDOMONAL SEPSIS 27 0.0154
140 ENTEROCOCCAL INFECTION 73 0.0151
141 ECTHYMA 6 0.0150
142 RESPIRATORY MONILIASIS 4 0.0149
143 DEVICE RELATED SEPSIS 30 0.0149
144 ANTIBIOTIC LEVEL ABOVE THERAPEUTIC 6 0.0148
145 SEPTIC EMBOLUS 12 0.0144
146 FIBRIN DEGRADATION PRODUCTS INCREASED 4 0.0135
147 BRAIN ABSCESS 34 0.0134
148 VENOOCCLUSIVE LIVER DISEASE 66 0.0134
149 CHRONIC GRAFT VERSUS HOST DISEASE 47 0.0130
150 RENAL HYPERTENSION 4 0.0129
151 INFECTION IN AN IMMUNOCOMPROMISED HOST 9 0.0125
152 ENTEROBACTER INFECTION 21 0.0125
153 CAT SCRATCH DISEASE 5 0.0124
154 CYTOMEGALOVIRUS VIRAEMIA 55 0.0124
155 USE OF ACCESSORY RESPIRATORY MUSCLES 5 0.0121
156 KLEBSIELLA INFECTION 61 0.0121
157 ENTEROVIRUS INFECTION 10 0.0116
158 GRAFT VERSUS HOST DISEASE 83 0.0115
159 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 24 0.0113
160 OESOPHAGEAL INFECTION 5 0.0112
161 CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER 4 0.0110
162 BOTULISM 9 0.0109
163 CHOLESTATIC LIVER INJURY 24 0.0108
164 ASPERGILLOSIS 14 0.0107
165 ESCHERICHIA SEPSIS 31 0.0107
166 NEUTROPENIC COLITIS 22 0.0106
167 INTENSIVE CARE UNIT ACQUIRED WEAKNESS 4 0.0105
168 PULMONARY CAVITATION 9 0.0103
169 BLASTOMYCOSIS 5 0.0103
170 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 34 0.0103
171 LOWER RESPIRATORY TRACT INFECTION FUNGAL 4 0.0103
172 CYSTITIS HAEMORRHAGIC 40 0.0099
173 MULTIPLE ORGAN DYSFUNCTION SYNDROME 281 0.0099
174 OBLITERATIVE BRONCHIOLITIS 13 0.0099
175 INFECTIOUS PLEURAL EFFUSION 15 0.0098
176 PNEUMONIA KLEBSIELLA 18 0.0098
177 VASOGENIC CEREBRAL OEDEMA 7 0.0097
178 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 9 0.0097
179 STAPHYLOCOCCAL BACTERAEMIA 42 0.0097
180 CANDIDA INFECTION 163 0.0096
181 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 17 0.0096
182 BACILLUS INFECTION 6 0.0095
183 MYCOBACTERIUM CHELONAE INFECTION 7 0.0095
184 POLYOMAVIRUS VIRAEMIA 10 0.0094
185 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 24 0.0093
186 HAEMOPHILUS INFECTION 9 0.0092
187 STAPHYLOCOCCAL SEPSIS 45 0.0091
188 LUNG TRANSPLANT REJECTION 6 0.0091
189 PSEUDOMEMBRANOUS COLITIS 20 0.0089
190 METAPNEUMOVIRUS INFECTION 7 0.0089
191 ESCHERICHIA BACTERAEMIA 21 0.0089
192 BLOOD FIBRINOGEN INCREASED 7 0.0089
193 DIFFUSE ALVEOLAR DAMAGE 10 0.0087
194 KIDNEY FIBROSIS 15 0.0086
195 ADENOVIRUS INFECTION 25 0.0086
196 VASCULAR DEVICE INFECTION 39 0.0086
197 BLAST CELL COUNT INCREASED 9 0.0086
198 CENTRAL NERVOUS SYSTEM HAEMORRHAGE 4 0.0086
199 EMPYEMA 17 0.0085
200 VENOOCCLUSIVE DISEASE 21 0.0084
201 PROTEUS INFECTION 6 0.0084
202 TOXOPLASMOSIS 9 0.0083
203 LIVER ABSCESS 27 0.0083
204 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 62 0.0083
205 CARDIAC VALVE VEGETATION 4 0.0082
206 MUCOUS MEMBRANE DISORDER 11 0.0080
207 PHARYNGEAL ABSCESS 4 0.0080
208 EPSTEIN-BARR VIRUS TEST POSITIVE 5 0.0079
209 CENTRAL NERVOUS SYSTEM INFECTION 9 0.0079
210 PNEUMONIA PSEUDOMONAL 12 0.0078
211 TRANSPLANT FAILURE 19 0.0077
212 DISSEMINATED INTRAVASCULAR COAGULATION 109 0.0077
213 PNEUMONIA NECROTISING 5 0.0077
214 VARICELLA ZOSTER VIRUS INFECTION 16 0.0077
215 ENDOCARDITIS BACTERIAL 6 0.0076
216 RENAL ABSCESS 6 0.0073
217 ACINETOBACTER INFECTION 8 0.0073
218 PATHOGEN RESISTANCE 66 0.0072
219 THROMBOTIC MICROANGIOPATHY 70 0.0072
220 HISTIOCYTOSIS HAEMATOPHAGIC 21 0.0071
221 ACUTE SINUSITIS 12 0.0070
222 SMALL INTESTINAL HAEMORRHAGE 14 0.0069
223 INCISION SITE PAIN 8 0.0068
224 CYTOMEGALOVIRUS INFECTION 113 0.0068
225 BLOOD CULTURE POSITIVE 20 0.0067
226 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 8 0.0067
227 LINEAR IGA DISEASE 11 0.0066
228 SECONDARY IMMUNODEFICIENCY 8 0.0066
229 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 39 0.0066
230 ORAL FUNGAL INFECTION 18 0.0066
231 FEBRILE NEUTROPENIA 435 0.0066
232 SKIN NECROSIS 34 0.0065
233 LEUKAEMIA RECURRENT 11 0.0065
234 STREPTOCOCCAL BACTERAEMIA 7 0.0064
235 LUNG CONSOLIDATION 18 0.0064
236 MEGACOLON 10 0.0064
237 BRAIN HERNIATION 19 0.0064
238 CLOSTRIDIUM TEST POSITIVE 14 0.0063
239 HYPERURICAEMIA 26 0.0063
240 EPSTEIN-BARR VIRAEMIA 7 0.0063
241 HYPOALBUMINAEMIA 49 0.0063
242 MENINGITIS CRYPTOCOCCAL 11 0.0063
243 CAPILLARY LEAK SYNDROME 13 0.0063
244 BK VIRUS INFECTION 21 0.0062
245 KLEBSIELLA SEPSIS 7 0.0062
246 RED BLOOD CELLS URINE POSITIVE 6 0.0062
247 RHINOVIRUS INFECTION 24 0.0062
248 KLEBSIELLA TEST POSITIVE 4 0.0061
249 APLASTIC ANAEMIA 32 0.0061
250 FUNCTIONAL GASTROINTESTINAL DISORDER 21 0.0061
251 CELL DEATH 12 0.0060
252 ILEAL PERFORATION 4 0.0060
253 EMBOLIC CEREBRAL INFARCTION 4 0.0060
254 CYTOKINE RELEASE SYNDROME 120 0.0060
255 STREPTOCOCCAL SEPSIS 7 0.0059
256 ENTERITIS INFECTIOUS 10 0.0059
257 CYTOKINE STORM 4 0.0058
258 COMPUTERISED TOMOGRAM THORAX ABNORMAL 4 0.0058
259 VIRAEMIA 8 0.0058
260 ATYPICAL MYCOBACTERIAL INFECTION 8 0.0057
261 ACUTE LYMPHOCYTIC LEUKAEMIA 16 0.0056
262 HYPERLEUKOCYTOSIS 5 0.0056
263 BACTERAEMIA 67 0.0056
264 MENINGITIS BACTERIAL 8 0.0056
265 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 13 0.0056
266 TUMOUR LYSIS SYNDROME 49 0.0056
267 CRYPTOCOCCOSIS 9 0.0055
268 INTRA-ABDOMINAL HAEMORRHAGE 13 0.0055
269 FUNGAL SKIN INFECTION 22 0.0054
270 VITH NERVE PARALYSIS 6 0.0053
271 SEPTIC SHOCK 229 0.0053
272 PULMONARY ALVEOLAR HAEMORRHAGE 29 0.0052
273 BILIRUBIN CONJUGATED INCREASED 12 0.0051
274 TRANSPLANT REJECTION 41 0.0051
275 ACUTE RESPIRATORY DISTRESS SYNDROME 90 0.0051
276 NEPHROPATHY TOXIC 57 0.0051
277 CEREBRAL HAEMATOMA 17 0.0051
278 PERITONEAL HAEMORRHAGE 7 0.0050
279 SERUM SICKNESS 14 0.0050
280 HYPERBILIRUBINAEMIA 52 0.0050
281 LUNG OPACITY 13 0.0049
282 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 13 0.0049
283 SHOCK HAEMORRHAGIC 39 0.0048
284 HYPERTRANSAMINASAEMIA 33 0.0047
285 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 24 0.0047
286 ACUTE MYELOID LEUKAEMIA 73 0.0047
287 PLATELET TRANSFUSION 6 0.0047
288 EOSINOPHILIC PNEUMONIA ACUTE 4 0.0046
289 APLASIA 9 0.0046
290 EPSTEIN-BARR VIRUS INFECTION 28 0.0045
291 WOUND DEHISCENCE 15 0.0044
292 PNEUMOMEDIASTINUM 8 0.0044
293 HYPOGAMMAGLOBULINAEMIA 29 0.0044
294 HISTOPLASMOSIS DISSEMINATED 7 0.0044
295 INTESTINAL INFARCTION 4 0.0044
296 ISCHAEMIC HEPATITIS 6 0.0044
297 METABOLIC ALKALOSIS 7 0.0044
298 URINARY TRACT INFECTION BACTERIAL 11 0.0043
299 LUNG ABSCESS 9 0.0043
300 THROMBOTIC THROMBOCYTOPENIC PURPURA 15 0.0043
301 DRUG RESISTANCE 109 0.0042
302 CATHETER SITE INFECTION 16 0.0042
303 NEUROLOGICAL SYMPTOM 24 0.0042
304 UPPER RESPIRATORY TRACT INFLAMMATION 5 0.0042
305 PNEUMONIA STAPHYLOCOCCAL 8 0.0041
306 HYPOFIBRINOGENAEMIA 4 0.0040
307 MUCOSAL DISORDER 4 0.0040
308 PRINZMETAL ANGINA 4 0.0040
309 CYTOMEGALOVIRUS COLITIS 9 0.0039
310 MULTI-ORGAN FAILURE 67 0.0039
311 PULMONARY HAEMORRHAGE 30 0.0038
312 NON-HODGKIN'S LYMPHOMA 5 0.0038
313 HYPERNATRAEMIA 19 0.0038
314 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 5 0.0038
315 GASTROENTERITIS NOROVIRUS 5 0.0038
316 FUNGAL INFECTION 125 0.0037
317 ADENOCARCINOMA OF COLON 7 0.0037
318 STRONGYLOIDIASIS 6 0.0037
319 MIXED LIVER INJURY 11 0.0037
320 ACUTE RESPIRATORY FAILURE 70 0.0036
321 RASH MORBILLIFORM 10 0.0036
322 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 4 0.0036
323 CYTOMEGALOVIRUS CHORIORETINITIS 7 0.0036
324 PULSELESS ELECTRICAL ACTIVITY 15 0.0036
325 RESPIRATORY ACIDOSIS 14 0.0036
326 GASTROINTESTINAL TOXICITY 17 0.0035
327 INFECTION REACTIVATION 4 0.0035
328 PUPILS UNEQUAL 4 0.0035
329 PNEUMOCYSTIS JIROVECII PNEUMONIA 35 0.0035
330 NEPHROGENIC DIABETES INSIPIDUS 4 0.0035
331 LABELLED DRUG-DRUG INTERACTION ISSUE 5 0.0035
332 MUCOSAL INFLAMMATION 88 0.0034
333 RESPIRATORY FAILURE 244 0.0033
334 ESCHERICHIA TEST POSITIVE 4 0.0033
335 LIVER TRANSPLANT REJECTION 6 0.0033
336 STEROID DIABETES 5 0.0033
337 STAPHYLOCOCCUS TEST POSITIVE 7 0.0033
338 SUSPECTED OFF LABEL USE 15 0.0033
339 HYPERCAPNIA 10 0.0033
340 CLOSTRIDIUM DIFFICILE COLITIS 35 0.0033
341 MONOCYTE COUNT DECREASED 4 0.0033
342 ORAL DISORDER 24 0.0033
343 PSEUDOMONAS INFECTION 28 0.0033
344 MYELITIS 5 0.0032
345 ORGAN FAILURE 13 0.0032
346 INTRAVENTRICULAR HAEMORRHAGE 8 0.0032
347 TORSADE DE POINTES 25 0.0032
348 HYPERAESTHESIA TEETH 4 0.0032
349 CYTOMEGALOVIRUS INFECTION REACTIVATION 14 0.0032
350 PNEUMONIA BACTERIAL 29 0.0032
351 SPINAL STENOSIS 13 0.0031
352 BACTERIAL TEST POSITIVE 7 0.0031
353 HYDROCEPHALUS 17 0.0031
354 DEVICE RELATED INFECTION 48 0.0031
355 PNEUMONIA CYTOMEGALOVIRAL 6 0.0031
356 RESPIRATORY ALKALOSIS 5 0.0031
357 PACKED RED BLOOD CELL TRANSFUSION 4 0.0030
358 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 15 0.0030
359 GLYCOSURIA 4 0.0030
360 ABDOMINAL ABSCESS 13 0.0029
361 HEPATIC NECROSIS 11 0.0029
362 ESCHERICHIA INFECTION 24 0.0029
363 MYCOBACTERIAL INFECTION 5 0.0029
364 OLIGURIA 18 0.0029
365 BILIARY TRACT DISORDER 4 0.0029
366 ENCEPHALITIS 20 0.0029
367 ACIDOSIS 22 0.0029
368 VASCULAR PSEUDOANEURYSM 5 0.0029
369 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 27 0.0028
370 TRANSPLANT DYSFUNCTION 5 0.0028
371 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 17 0.0028
372 HYPERPHOSPHATAEMIA 6 0.0028
373 CYTOPENIA 34 0.0028
374 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 14 0.0028
375 SEPSIS 308 0.0028
376 CANDIDIASIS 11 0.0027
377 ENDOCARDITIS 14 0.0027
378 HYPOXIA 96 0.0027
379 LYMPHOPROLIFERATIVE DISORDER 8 0.0027
380 OTOTOXICITY 5 0.0027
381 HAEMORRHAGIC TRANSFORMATION STROKE 4 0.0027
382 SERUM FERRITIN INCREASED 14 0.0027
383 PROCTALGIA 17 0.0026
384 HAEMODYNAMIC INSTABILITY 20 0.0026
385 ORGANISING PNEUMONIA 13 0.0026
386 HYPOKALAEMIA 121 0.0026
387 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 10 0.0026
388 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 4 0.0026
389 HEPATIC FUNCTION ABNORMAL 97 0.0026
390 HAEMOLYTIC URAEMIC SYNDROME 6 0.0026
391 OESOPHAGITIS 28 0.0026
392 BLOOD BILIRUBIN INCREASED 69 0.0026
393 PULMONARY MASS 38 0.0025
394 RESPIRATORY SYNCYTIAL VIRUS INFECTION 22 0.0025
395 GENE MUTATION 5 0.0025
396 PANCYTOPENIA 141 0.0025
397 LACUNAR INFARCTION 6 0.0025
398 TOXIC EPIDERMAL NECROLYSIS 38 0.0025
399 ENDOTRACHEAL INTUBATION 7 0.0025
400 VASCULITIS 29 0.0025
401 LYMPHOCYTE COUNT DECREASED 44 0.0025
402 ACUTE LEUKAEMIA 4 0.0025
403 OESOPHAGEAL STENOSIS 7 0.0025
404 SUBARACHNOID HAEMORRHAGE 25 0.0025
405 HAEMATOLOGICAL INFECTION 6 0.0025
406 LUNG INFECTION 38 0.0024
407 PSYCHIATRIC SYMPTOM 18 0.0024
408 HYPERVOLAEMIA 12 0.0024
409 TACHYPNOEA 33 0.0024
410 STAPHYLOCOCCAL INFECTION 80 0.0024
411 ASPARTATE AMINOTRANSFERASE INCREASED 128 0.0024
412 STEM CELL TRANSPLANT 6 0.0024
413 GASTROINTESTINAL NECROSIS 7 0.0024
414 PLEURAL EFFUSION 146 0.0024
415 BLOOD UREA INCREASED 40 0.0024
416 LUNG INFILTRATION 21 0.0024
417 ENCEPHALOPATHY 58 0.0024
418 BACTERIAL INFECTION 44 0.0024
419 DRUG LEVEL BELOW THERAPEUTIC 13 0.0024
420 MYELOSUPPRESSION 84 0.0023
421 BONE MARROW FAILURE 47 0.0023
422 FAILURE TO THRIVE 12 0.0023
423 LARGE INTESTINE PERFORATION 16 0.0023
424 HYPOPHOSPHATAEMIA 17 0.0023
425 COAGULOPATHY 38 0.0023
426 SHOCK 52 0.0023
427 ATRIAL FLUTTER 18 0.0023
428 CARDIAC FAILURE ACUTE 15 0.0022
429 PNEUMOCYSTIS JIROVECI PNEUMONIA 5 0.0022
430 ILEUS PARALYTIC 10 0.0022
431 MYCOBACTERIUM AVIUM COMPLEX INFECTION 6 0.0022
432 MALNUTRITION 25 0.0022
433 HYPERTRIGLYCERIDAEMIA 13 0.0022
434 MONOPARESIS 4 0.0022
435 COMPLICATIONS OF TRANSPLANTED KIDNEY 5 0.0022
436 HYPERLIPIDAEMIA 26 0.0022
437 ATELECTASIS 21 0.0022
438 PNEUMOPERITONEUM 4 0.0022
439 BLOOD ALBUMIN DECREASED 17 0.0021
440 ALANINE AMINOTRANSFERASE INCREASED 131 0.0021
441 PERICARDIAL EFFUSION 49 0.0021
442 HYPOPROTEINAEMIA 4 0.0021
443 DIABETES INSIPIDUS 5 0.0021
444 DRUG-INDUCED LIVER INJURY 65 0.0021
445 BRAIN OEDEMA 26 0.0021
446 RENAL TUBULAR NECROSIS 20 0.0020
447 MULTI-ORGAN DISORDER 4 0.0020
448 LUNG TRANSPLANT 7 0.0020
449 TOXIC ENCEPHALOPATHY 10 0.0020
450 PANCREATITIS ACUTE 44 0.0020
451 BLOOD LACTATE DEHYDROGENASE INCREASED 31 0.0020
452 NOCARDIOSIS 5 0.0020
453 HEPATOSPLENOMEGALY 5 0.0019
454 MENINGITIS 13 0.0019
455 NEUTROPENIA 264 0.0019
456 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 15 0.0019
457 RESPIRATORY DISTRESS 53 0.0019
458 RENAL IMPAIRMENT 161 0.0019
459 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 104 0.0019
460 HEPATIC FAILURE 57 0.0019
461 FEBRILE BONE MARROW APLASIA 8 0.0019
462 HYPOVOLAEMIC SHOCK 9 0.0019
463 HYPERCALCAEMIA 23 0.0019
464 PROTEIN TOTAL DECREASED 7 0.0019
465 ABSCESS INTESTINAL 4 0.0019
466 NEUTROPHIL COUNT DECREASED 75 0.0018
467 BLOOD PHOSPHORUS INCREASED 5 0.0018
468 PNEUMOTHORAX 29 0.0018
469 NEUROTOXICITY 32 0.0018
470 EOSINOPHILIA 32 0.0018
471 NOSOCOMIAL INFECTION 4 0.0018
472 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 4 0.0018
473 PLEURITIC PAIN 5 0.0018
474 DRUG ERUPTION 32 0.0018
475 PROTEIN URINE PRESENT 9 0.0018
476 STREPTOCOCCAL INFECTION 10 0.0018
477 RENAL TUBULAR DISORDER 5 0.0018
478 BLOOD PRESSURE SYSTOLIC DECREASED 8 0.0018
479 NEUTROPHIL COUNT INCREASED 18 0.0018
480 NEUROLOGICAL DECOMPENSATION 4 0.0017
481 HYPOMAGNESAEMIA 24 0.0017
482 GAMMA-GLUTAMYLTRANSFERASE INCREASED 38 0.0017
483 LEUKOCYTOSIS 31 0.0017
484 PAPULE 12 0.0017
485 DIFFUSE LARGE B-CELL LYMPHOMA 13 0.0017
486 CONJUNCTIVAL HYPERAEMIA 6 0.0017
487 DRUG LEVEL DECREASED 17 0.0017
488 AGRANULOCYTOSIS 31 0.0017
489 STEVENS-JOHNSON SYNDROME 37 0.0017
490 TRANSAMINASES INCREASED 37 0.0017
491 ACUTE KIDNEY INJURY 254 0.0017
492 BLOOD ALKALINE PHOSPHATASE INCREASED 41 0.0016
493 FLUID OVERLOAD 24 0.0016
494 LEUKOPENIA 82 0.0016
495 BRONCHITIS CHRONIC 4 0.0016
496 MOUTH HAEMORRHAGE 12 0.0016
497 VENTRICULAR TACHYCARDIA 27 0.0016
498 DUODENITIS 5 0.0016
499 BRAIN DEATH 5 0.0016
500 GENERALISED OEDEMA 20 0.0016
501 MULTIPLE-DRUG RESISTANCE 5 0.0016
502 HYPERAMMONAEMIA 8 0.0016
503 ASCITES 47 0.0016
504 BLOOD CREATININE DECREASED 5 0.0016
505 SPINAL COMPRESSION FRACTURE 13 0.0016
506 PNEUMONIA VIRAL 5 0.0016
507 ABDOMINAL INFECTION 4 0.0016
508 PHYSICAL DECONDITIONING 4 0.0016
509 SKIN EROSION 5 0.0016
510 RASH MACULO-PAPULAR 34 0.0015
511 COVID-19 PNEUMONIA 18 0.0015
512 POLYDIPSIA 6 0.0015
513 LIVER DISORDER 67 0.0015
514 OESOPHAGEAL CANDIDIASIS 6 0.0015
515 PERITONITIS 31 0.0015
516 TOXIC SKIN ERUPTION 15 0.0015
517 CLOSTRIDIAL INFECTION 5 0.0015
518 INTESTINAL ISCHAEMIA 8 0.0015
519 MYELODYSPLASTIC SYNDROME 21 0.0015
520 CHOLANGITIS 9 0.0015
521 ORAL CANDIDIASIS 19 0.0014
522 HEPATOTOXICITY 32 0.0014
523 CEREBRAL INFARCTION 35 0.0014
524 THROMBOPHLEBITIS 5 0.0014
525 CLOSTRIDIUM DIFFICILE INFECTION 31 0.0014
526 INFLAMMATORY MARKER INCREASED 7 0.0014
527 PYREXIA 487 0.0014
528 FIBRIN D DIMER INCREASED 5 0.0014
529 HAEMORRHAGIC DIATHESIS 5 0.0014
530 HEPATIC ENZYME ABNORMAL 7 0.0014
531 ELECTROCARDIOGRAM QT PROLONGED 50 0.0014
532 ENTEROCOLITIS 8 0.0014
533 DERMATITIS BULLOUS 10 0.0014
534 METABOLIC DISORDER 8 0.0014
535 CEREBRAL HAEMORRHAGE 49 0.0014
536 CHOLESTASIS 26 0.0014
537 LEFT VENTRICULAR DYSFUNCTION 9 0.0013
538 TONSILLITIS 7 0.0013
539 HAEMORRHAGE INTRACRANIAL 20 0.0013
540 PROTHROMBIN TIME PROLONGED 8 0.0013
541 METABOLIC ENCEPHALOPATHY 4 0.0013
542 NEPHROTIC SYNDROME 9 0.0013
543 DRUG LEVEL ABOVE THERAPEUTIC 6 0.0013
544 INTERSTITIAL LUNG DISEASE 63 0.0013
545 BRUXISM 7 0.0013
546 HAEMOLYSIS 10 0.0013
547 PRODUCT USE IN UNAPPROVED INDICATION 320 0.0013
548 NEPHROPATHY 12 0.0013
549 APPENDICITIS 12 0.0013
550 METABOLIC ACIDOSIS 41 0.0013
551 FAECALOMA 7 0.0013
552 PLATELET COUNT DECREASED 136 0.0013
553 LYMPHOPENIA 18 0.0013
554 MELAENA 28 0.0013
555 MENTAL STATUS CHANGES 35 0.0013
556 HAEMOPTYSIS 35 0.0013
557 SUPRAVENTRICULAR TACHYCARDIA 12 0.0013
558 KIDNEY TRANSPLANT REJECTION 6 0.0012
559 BLOOD CALCIUM DECREASED 14 0.0012
560 TRIGEMINAL NEURALGIA 5 0.0012
561 PORTAL VEIN THROMBOSIS 4 0.0012
562 CIRCULATORY COLLAPSE 21 0.0012
563 HEPARIN-INDUCED THROMBOCYTOPENIA 6 0.0012
564 LIVER FUNCTION TEST INCREASED 26 0.0012
565 OTITIS MEDIA 4 0.0012
566 CORONAVIRUS INFECTION 8 0.0012
567 ILEUS 15 0.0012
568 DERMATITIS EXFOLIATIVE 6 0.0012
569 PERIPHERAL SENSORY NEUROPATHY 7 0.0012
570 ABSCESS 19 0.0012
571 BRONCHIECTASIS 8 0.0012
572 POSTOPERATIVE WOUND INFECTION 8 0.0012
573 C-REACTIVE PROTEIN INCREASED 43 0.0012
574 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 12 0.0012
575 AUTOIMMUNE HAEMOLYTIC ANAEMIA 4 0.0012
576 CEREBRAL ISCHAEMIA 6 0.0012
577 CENTRAL NERVOUS SYSTEM LESION 16 0.0012
578 UNRESPONSIVE TO STIMULI 30 0.0012
579 ANURIA 10 0.0012
580 PNEUMONIA ASPIRATION 29 0.0012
581 MALABSORPTION 6 0.0011
582 DRUG LEVEL INCREASED 19 0.0011
583 URINE OUTPUT DECREASED 10 0.0011
584 RIGHT VENTRICULAR FAILURE 8 0.0011
585 THROMBOCYTOPENIA 127 0.0011
586 DEPRESSIVE SYMPTOM 4 0.0011
587 NECROTISING FASCIITIS 4 0.0011
588 CONCOMITANT DISEASE AGGRAVATED 7 0.0011
589 PULMONARY TOXICITY 8 0.0011
590 TUBULOINTERSTITIAL NEPHRITIS 21 0.0011
591 NEUTROPENIC SEPSIS 8 0.0011
592 ANAL ABSCESS 6 0.0011
593 IRON DEFICIENCY 5 0.0011
594 ALTERED STATE OF CONSCIOUSNESS 24 0.0011
595 BLOOD PHOSPHORUS DECREASED 4 0.0011
596 UROSEPSIS 10 0.0011
597 COLITIS 41 0.0011
598 CARDIAC DYSFUNCTION 4 0.0011
599 LEUKOENCEPHALOPATHY 4 0.0011
600 ADRENAL INSUFFICIENCY 13 0.0011
601 RENAL FAILURE 142 0.0011
602 SMALL INTESTINAL OBSTRUCTION 13 0.0011
603 PETECHIAE 11 0.0011
604 CARDIAC ARREST 87 0.0011
605 SKIN MASS 7 0.0010
606 BLOOD CREATININE INCREASED 68 0.0010
607 OESOPHAGEAL ULCER 4 0.0010
608 BLOOD URIC ACID INCREASED 6 0.0010
609 STOMATITIS 63 0.0010
610 ELECTROLYTE IMBALANCE 12 0.0010
611 PNEUMONITIS 28 0.0010
612 HAEMORRHAGIC STROKE 8 0.0010
613 DISEASE PROGRESSION 121 0.0010
614 INFECTION 148 0.0010
615 LACTIC ACIDOSIS 33 0.0010
616 HYPOCALCAEMIA 19 0.0010
617 AZOTAEMIA 4 0.0010
618 THERAPY NON-RESPONDER 45 0.0010
619 HYPERKALAEMIA 35 0.0010
620 MIOSIS 8 0.0010
621 DYSPHORIA 5 0.0010
622 WHITE BLOOD CELL COUNT DECREASED 107 0.0010
623 DECUBITUS ULCER 8 0.0010
624 POLYURIA 8 0.0010
625 CACHEXIA 5 0.0010
626 PNEUMONIA 313 0.0010
627 WHITE BLOOD CELL COUNT INCREASED 37 0.0010
628 RASH PUSTULAR 7 0.0010
629 LOWER GASTROINTESTINAL HAEMORRHAGE 7 0.0009
630 DRUG INTERACTION 149 0.0009
631 HYPOPHAGIA 24 0.0009
632 LUNG NEOPLASM 4 0.0009
633 PURULENT DISCHARGE 4 0.0009
634 HYPERGLYCAEMIA 34 0.0009
635 BLOOD MAGNESIUM DECREASED 8 0.0009
636 HEPATIC LESION 4 0.0009
637 HERPES SIMPLEX 6 0.0009
638 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 5 0.0009
639 HEPATOMEGALY 9 0.0009
640 LIPASE INCREASED 7 0.0009
641 PARONYCHIA 4 0.0009
642 SUBDURAL HAEMATOMA 13 0.0009
643 HAEMATOCRIT DECREASED 18 0.0009
644 IMMUNOSUPPRESSION 8 0.0009
645 CYSTIC FIBROSIS 5 0.0009
646 VENTRICULAR FIBRILLATION 10 0.0009
647 NECROSIS 5 0.0009
648 GASTROINTESTINAL HAEMORRHAGE 75 0.0009
649 NERVOUS SYSTEM DISORDER 28 0.0009
650 LIVER INJURY 22 0.0009
651 PULMONARY OEDEMA 40 0.0009
652 HAEMOLYTIC ANAEMIA 8 0.0009
653 ACUTE PULMONARY OEDEMA 5 0.0009
654 HYPOTHERMIA 9 0.0009
655 OSTEOMYELITIS 16 0.0009
656 ANAEMIA 166 0.0009
657 HICCUPS 7 0.0009
658 CYSTITIS 27 0.0008
659 TREATMENT FAILURE 70 0.0008
660 LYMPHOMA 13 0.0008
661 EOSINOPHIL COUNT INCREASED 7 0.0008
662 DRUG INEFFECTIVE 1105 0.0008
663 HYPONATRAEMIA 47 0.0008
664 RENAL FAILURE ACUTE 35 0.0008
665 HYPOGLYCAEMIA 40 0.0008
666 FACIAL PARALYSIS 7 0.0008
667 HAEMATURIA 28 0.0008
668 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 21 0.0008
669 DELIRIUM 28 0.0008
670 ABDOMINAL TENDERNESS 4 0.0008
671 ACUTE HEPATIC FAILURE 11 0.0008
672 PANCREATITIS 42 0.0008
673 CELLULITIS 40 0.0008
674 OFF LABEL USE 691 0.0008
675 CARDIOTOXICITY 7 0.0008
676 ENTERITIS 5 0.0008
677 PHLEBITIS 4 0.0008
678 DIALYSIS 11 0.0008
679 SINUS TACHYCARDIA 11 0.0008
680 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 18 0.0008
681 GASTROINTESTINAL INFLAMMATION 6 0.0008
682 ATRIAL FIBRILLATION 74 0.0008
683 BLOOD LACTIC ACID INCREASED 4 0.0008
684 WALKING AID USER 5 0.0008
685 CARDIAC FAILURE 60 0.0007
686 COMPRESSION FRACTURE 4 0.0007
687 CARDIOMYOPATHY 11 0.0007
688 TACHYCARDIA 66 0.0007
689 GINGIVITIS 4 0.0007
690 ASPIRATION 8 0.0007
691 ECCHYMOSIS 5 0.0007
692 HERPES ZOSTER 41 0.0007
693 UPPER GASTROINTESTINAL HAEMORRHAGE 12 0.0007
694 HYPOTENSION 142 0.0007
695 NEUTROPHILIA 4 0.0007
696 GRANULOCYTOPENIA 4 0.0007
697 PARALYSIS 10 0.0007
698 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 5 0.0007
699 RASH ERYTHEMATOUS 33 0.0007
700 HYPOVOLAEMIA 4 0.0007
701 SPLENOMEGALY 8 0.0007
702 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 6 0.0007
703 LYMPHADENOPATHY 24 0.0007
704 BLOOD POTASSIUM INCREASED 11 0.0007
705 PULMONARY HYPERTENSION 14 0.0007
706 MYOSITIS 6 0.0007
707 ENDOPHTHALMITIS 4 0.0007
708 CONDITION AGGRAVATED 202 0.0007
709 GANGRENE 4 0.0007
710 BLOOD CREATINE PHOSPHOKINASE INCREASED 19 0.0007
711 HAEMOGLOBIN DECREASED 67 0.0007
712 HEMIPARESIS 11 0.0006
713 EJECTION FRACTION DECREASED 10 0.0006
714 INTERVERTEBRAL DISC PROTRUSION 14 0.0006
715 CYANOSIS 10 0.0006
716 HEPATOCELLULAR INJURY 9 0.0006
717 HEPATIC ENZYME INCREASED 43 0.0006
718 OBSTRUCTIVE AIRWAYS DISORDER 7 0.0006
719 CARDIOGENIC SHOCK 9 0.0006
720 INTESTINAL PERFORATION 7 0.0006
721 RENAL DISORDER 29 0.0006
722 CARDIO-RESPIRATORY ARREST 26 0.0006
723 MYOCARDITIS 7 0.0006
724 COMA 29 0.0006
725 GENERALISED TONIC-CLONIC SEIZURE 10 0.0006
726 EMBOLISM 5 0.0006
727 BLOOD POTASSIUM DECREASED 18 0.0006
728 CHOLECYSTITIS 7 0.0006
729 OXYGEN SATURATION DECREASED 33 0.0006
730 MATERNAL EXPOSURE BEFORE PREGNANCY 4 0.0006
731 VENTRICULAR EXTRASYSTOLES 6 0.0006
732 NO THERAPEUTIC RESPONSE 7 0.0006
733 OEDEMA 31 0.0006
734 GASTRITIS 15 0.0006
735 RESPIRATORY DISORDER 17 0.0006
736 DUODENAL ULCER 4 0.0006
737 PURPURA 5 0.0006
738 PLASMA CELL MYELOMA 22 0.0006
739 DEPRESSED LEVEL OF CONSCIOUSNESS 22 0.0006
740 HAEMATEMESIS 14 0.0006
741 RESPIRATORY ARREST 15 0.0005
742 HAEMATOCHEZIA 29 0.0005
743 HYPERTHERMIA 4 0.0005
744 MOUTH ULCERATION 11 0.0005
745 JAUNDICE 14 0.0005
746 UVEITIS 7 0.0005
747 INFUSION RELATED REACTION 34 0.0005
748 THERAPY PARTIAL RESPONDER 8 0.0005
749 BLOOD PRESSURE DECREASED 34 0.0005
750 ARRHYTHMIA 24 0.0005
751 DISEASE RECURRENCE 24 0.0005
752 ISCHAEMIC STROKE 9 0.0005
753 GENERAL PHYSICAL HEALTH DETERIORATION 58 0.0005
754 ABDOMINAL PAIN 116 0.0005
755 END STAGE RENAL DISEASE 9 0.0005
756 TOOTH ABSCESS 5 0.0005
757 RED BLOOD CELL COUNT DECREASED 14 0.0005
758 GLOMERULAR FILTRATION RATE DECREASED 6 0.0005
759 CARDIOMEGALY 6 0.0005
760 COMPLICATION ASSOCIATED WITH DEVICE 7 0.0005
761 HEMIPLEGIA 4 0.0005
762 URINARY RETENTION 16 0.0005
763 HAEMODIALYSIS 4 0.0005
764 FACE OEDEMA 8 0.0005
765 HYPERTENSION 100 0.0005
766 BRADYCARDIA 25 0.0005
767 IMMUNODEFICIENCY 7 0.0005
768 LUNG DISORDER 23 0.0005
769 APHASIA 14 0.0005
770 PYELONEPHRITIS 4 0.0005
771 PRODUCT PRESCRIBING ISSUE 10 0.0005
772 EPILEPSY 14 0.0005
773 NAIL DISORDER 4 0.0005
774 PULMONARY CONGESTION 6 0.0005
775 PRESYNCOPE 11 0.0005
776 RESPIRATORY RATE INCREASED 4 0.0005
777 ORAL PAIN 10 0.0004
778 CHROMATURIA 10 0.0004
779 REBOUND EFFECT 5 0.0004
780 PRODUCTIVE COUGH 21 0.0004
781 HIDRADENITIS 4 0.0004
782 DERMATITIS CONTACT 5 0.0004
783 SKIN LESION 12 0.0004
784 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 31 0.0004
785 GASTRIC HAEMORRHAGE 5 0.0004
786 SEIZURE 49 0.0004
787 DIARRHOEA 271 0.0004
788 MYOCLONUS 5 0.0004
789 GLAUCOMA 8 0.0004
790 UPPER RESPIRATORY TRACT INFECTION 19 0.0004
791 GASTROENTERITIS 6 0.0004
792 PALLOR 11 0.0004
793 PHARYNGITIS 5 0.0004
794 NEOPLASM PROGRESSION 14 0.0004
795 EYELID PTOSIS 4 0.0004
796 ABDOMINAL DISTENSION 41 0.0004
797 BODY TEMPERATURE INCREASED 8 0.0004
798 HIATUS HERNIA 5 0.0004
799 INTERNATIONAL NORMALISED RATIO INCREASED 11 0.0004
800 RHABDOMYOLYSIS 16 0.0004
801 RESTLESSNESS 14 0.0004
802 DERMATITIS 8 0.0004
803 IMMUNE SYSTEM DISORDER 5 0.0004
804 ACUTE MYOCARDIAL INFARCTION 11 0.0004
805 BLOOD SODIUM DECREASED 7 0.0004
806 PHOTOSENSITIVITY REACTION 6 0.0004
807 EXTRAPYRAMIDAL DISORDER 9 0.0004
808 PRESCRIBED OVERDOSE 7 0.0004
809 VIRAL INFECTION 12 0.0004
810 PERICARDITIS 6 0.0004
811 HEPATITIS 9 0.0004
812 MALIGNANT NEOPLASM PROGRESSION 36 0.0004
813 SINUSITIS 36 0.0004
814 RECTAL HAEMORRHAGE 15 0.0003
815 ANAPHYLACTIC SHOCK 9 0.0003
816 METASTASES TO LUNG 4 0.0003
817 RESPIRATORY TRACT INFECTION 9 0.0003
818 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 10 0.0003
819 CHILLS 40 0.0003
820 RENAL INJURY 10 0.0003
821 HALLUCINATION, VISUAL 7 0.0003
822 INTENTIONAL PRODUCT USE ISSUE 29 0.0003
823 THERAPEUTIC RESPONSE DECREASED 20 0.0003
824 HAEMORRHAGE 34 0.0003
825 DIVERTICULITIS 9 0.0003
826 EPISTAXIS 24 0.0003
827 PROTEINURIA 6 0.0003
828 HYPOTHYROIDISM 10 0.0003
829 INTRAOCULAR PRESSURE INCREASED 4 0.0003
830 POST PROCEDURAL COMPLICATION 6 0.0003
831 LIVER FUNCTION TEST ABNORMAL 9 0.0003
832 HAEMATOMA 8 0.0003
833 PRODUCT USE ISSUE 58 0.0003
834 TOXICITY TO VARIOUS AGENTS 52 0.0003
835 DEAFNESS 8 0.0003
836 URINARY TRACT INFECTION 52 0.0003
837 OEDEMA PERIPHERAL 37 0.0003
838 FULL BLOOD COUNT DECREASED 6 0.0003
839 GINGIVAL BLEEDING 4 0.0003
840 INFLAMMATION 15 0.0003
841 ANAPHYLACTIC REACTION 16 0.0003
842 VOMITING 136 0.0003
843 AMENORRHOEA 5 0.0003
844 BLOOD TRIGLYCERIDES INCREASED 5 0.0003
845 BRONCHOSPASM 4 0.0003
846 PULMONARY ARTERIAL HYPERTENSION 4 0.0003
847 FLUID RETENTION 14 0.0003
848 DRUG EFFECT LESS THAN EXPECTED 4 0.0003
849 DYSARTHRIA 10 0.0003
850 BLOOD COUNT ABNORMAL 4 0.0003
851 RASH 115 0.0003
852 GASTRIC ULCER 5 0.0003
853 BRONCHITIS 19 0.0003
854 COVID-19 45 0.0003
855 BONE PAIN 15 0.0003
856 NEUROPATHY PERIPHERAL 24 0.0003
857 CHRONIC KIDNEY DISEASE 19 0.0002
858 LOSS OF CONSCIOUSNESS 32 0.0002
859 DYSPNOEA 141 0.0002
860 CONSTIPATION 54 0.0002
861 DYSKINESIA 10 0.0002
862 IMPAIRED HEALING 8 0.0002
863 EATING DISORDER 5 0.0002
864 METRORRHAGIA 4 0.0002
865 DECREASED APPETITE 54 0.0002
866 SKIN ULCER 6 0.0002
867 FAECES DISCOLOURED 5 0.0002
868 DEHYDRATION 30 0.0002
869 OROPHARYNGEAL PAIN 20 0.0002
870 DEEP VEIN THROMBOSIS 14 0.0002
871 BLISTER 12 0.0002
872 CHOLELITHIASIS 7 0.0002
873 HEPATIC CIRRHOSIS 4 0.0002
874 PHOTOPHOBIA 4 0.0002
875 PAIN IN JAW 6 0.0002
876 CONVULSION 12 0.0002
877 NAUSEA 166 0.0002
878 LETHARGY 12 0.0002
879 MENTAL DISORDER 9 0.0002
880 DISORIENTATION 8 0.0002
881 CONFUSIONAL STATE 32 0.0002
882 SWELLING 18 0.0002
883 DEATH 162 0.0002
884 DYSPNOEA EXERTIONAL 7 0.0002
885 COUGH 52 0.0002
886 INCORRECT PRODUCT ADMINISTRATION DURATION 4 0.0002
887 BLOOD GLUCOSE INCREASED 34 0.0002
888 SKIN DISORDER 6 0.0002
889 PULMONARY EMBOLISM 17 0.0002
890 GASTROINTESTINAL DISORDER 16 0.0002
891 CARDIAC FAILURE CONGESTIVE 14 0.0002
892 INSOMNIA 46 0.0002
893 PALPITATIONS 20 0.0002
894 INFLUENZA 19 0.0002
895 SYNCOPE 17 0.0002
896 SYSTEMIC LUPUS ERYTHEMATOSUS 6 0.0002
897 DYSPHAGIA 16 0.0002
898 CHEST DISCOMFORT 17 0.0002
899 SKIN EXFOLIATION 14 0.0002
900 NEURALGIA 4 0.0002
901 UNDERDOSE 12 0.0002
902 DYSURIA 6 0.0002
903 INTESTINAL OBSTRUCTION 6 0.0002
904 GASTRIC CANCER 4 0.0002
905 DIABETES MELLITUS 12 0.0002
906 TREMOR 26 0.0002
907 BACK PAIN 36 0.0002
908 RASH GENERALISED 4 0.0002
909 VISION BLURRED 21 0.0002
910 GASTROOESOPHAGEAL REFLUX DISEASE 12 0.0001
911 RASH PRURITIC 8 0.0001
912 ERYTHEMA 29 0.0001
913 ADVERSE EVENT 13 0.0001
914 MUSCULAR WEAKNESS 16 0.0001
915 WEIGHT DECREASED 39 0.0001
916 RHINORRHOEA 9 0.0001
917 WEIGHT INCREASED 31 0.0001
918 VISUAL IMPAIRMENT 17 0.0001
919 LABORATORY TEST ABNORMAL 4 0.0001
920 CHEST PAIN 25 0.0001
921 DRUG INTOLERANCE 13 0.0001
922 CONTRAINDICATED PRODUCT ADMINISTERED 4 0.0001
923 TREATMENT NONCOMPLIANCE 7 0.0001
924 BLINDNESS 5 0.0001
925 NO ADVERSE EVENT 22 0.0001
926 HALLUCINATION 9 0.0001
927 SOMNOLENCE 23 0.0001
928 INTENTIONAL PRODUCT MISUSE 10 0.0001
929 HEADACHE 71 0.0001
930 ANGIOEDEMA 5 0.0001
931 THROMBOSIS 9 0.0001
932 MYALGIA 19 0.0001
933 ABDOMINAL PAIN UPPER 23 0.0001
934 AGITATION 8 0.0001
935 TINNITUS 5 0.0001
936 SKIN DISCOLOURATION 5 0.0001
937 MATERNAL EXPOSURE DURING PREGNANCY 9 0.0001
938 HYPERHIDROSIS 13 0.0001
939 DRY EYE 5 0.0001
940 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 18 0.0001
941 SLEEP DISORDER 7 0.0001
942 ILL-DEFINED DISORDER 6 0.0001
943 MUSCULOSKELETAL PAIN 5 0.0001
944 SPEECH DISORDER 5 0.0001
945 SWELLING FACE 6 0.0001
946 HOSPITALISATION 14 0.0001
947 PAIN 55 0.0001
948 NECK PAIN 5 0.0001
949 EYE PAIN 5 0.0001
950 COGNITIVE DISORDER 4 0.0001
951 DYSPHONIA 5 0.0001
952 ASTHENIA 32 0.0001
953 PAIN IN EXTREMITY 25 0.0001
954 CATARACT 5 0.0001
955 OVERDOSE 18 0.0001
956 CEREBROVASCULAR ACCIDENT 14 0.0001
957 MALAISE 36 0.0001
958 BALANCE DISORDER 7 0.0001
959 HYPERSENSITIVITY 15 0.0001
960 PRURITUS 31 0.0001
961 EXPOSURE DURING PREGNANCY 5 0.0001
962 BLOOD PRESSURE INCREASED 12 0.0001
963 FALL 26 0.0001
964 ABDOMINAL DISCOMFORT 13 0.0001
965 ECZEMA 4 0.0001
966 FATIGUE 57 0.0001
967 URTICARIA 12 0.0001
968 PARAESTHESIA 11 0.0001
969 DIZZINESS 34 0.0001
970 GAIT DISTURBANCE 13 0.0001
971 PERIPHERAL SWELLING 9 0.0001
972 ARTHRALGIA 24 0.0001
973 DEVICE MALFUNCTION 4 0.0001
974 MUSCLE SPASMS 10 0.0001
975 HYPOAESTHESIA 8 0.0001
976 ASTHMA 6 0.0001
977 CONTUSION 5 0.0001
978 ANXIETY 14 0.0000
979 INFLUENZA LIKE ILLNESS 4 0.0000
980 ILLNESS 5 0.0000
981 MYOCARDIAL INFARCTION 8 0.0000
982 MUSCULOSKELETAL STIFFNESS 4 0.0000
983 NASOPHARYNGITIS 8 0.0000
984 CARDIAC DISORDER 4 0.0000
985 ALOPECIA 8 0.0000
986 DYSPEPSIA 4 0.0000
987 HEART RATE INCREASED 4 0.0000
988 DEPRESSION 9 0.0000
989 MEMORY IMPAIRMENT 5 0.0000
990 JOINT SWELLING 4 0.0000
991 PRODUCT DOSE OMISSION ISSUE 9 0.0000
992 DRUG DOSE OMISSION 4 0.0000
993 INCORRECT DOSE ADMINISTERED 5 0.0000
994 INJECTION SITE PAIN 4 0.0000